NIFK, an independent prognostic biomarker of hepatocellular carcinoma, is correlated with immune infiltration

Singal, 2020, Epidemiology and surveillance for hepatocellular carcinoma: New trends, J Hepatol, 72, 250, 10.1016/j.jhep.2019.08.025 Sartoris, 2021, HCC advances in diagnosis and prognosis: Digital and Imaging, Liver Int, 41, 73, 10.1111/liv.14865 Sung, 2021, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 71, 209, 10.3322/caac.21660 Fitzmaurice, 2019, Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: A systematic analysis for the global burden of disease study, JAMA Oncol, 5, 1749, 10.1001/jamaoncol.2019.2996 Kulik, 2019, Epidemiology and management of hepatocellular carcinoma, Gastroenterology, 156, 477, 10.1053/j.gastro.2018.08.065 Yang, 2019, A global view of hepatocellular carcinoma: trends, risk, prevention and management, Nat Rev Gastroenterol Hepatol, 16, 589, 10.1038/s41575-019-0186-y Yip, 2022, Asian perspective on NAFLD-associated HCC, J Hepatol, 76, 726, 10.1016/j.jhep.2021.09.024 Malek, 2014, The diagnosis and treatment of hepatocellular carcinoma, Dtsch Arztebl Int, 111, 101 Takagi, 2001, A novel nucleolar protein, NIFK, interacts with the forkhead associated domain of Ki-67 antigen in mitosis, J Biol Chem, 276, 25386, 10.1074/jbc.M102227200 Scholzen, 2000, The Ki-67 protein: from the known and the unknown, J Cell Physiol, 182, 311, 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9 Menon, 2019, Ki-67 protein as a tumour proliferation marker, Clin Chim Acta, 491, 39, 10.1016/j.cca.2019.01.011 Byeon, 2005, Sequential phosphorylation and multisite interactions characterize specific target recognition by the FHA domain of Ki67, Nat Struct Mol Biol, 12, 987, 10.1038/nsmb1008 Schlosser, 2003, A role for c-Myc in the regulation of ribosomal RNA processing, Nucleic Acids Res, 31, 6148, 10.1093/nar/gkg794 Musgrove, 2008, Identification of functional networks of estrogen- and c-Myc-responsive genes and their relationship to response to tamoxifen therapy in breast cancer, PLoS One, 3, e2987, 10.1371/journal.pone.0002987 Abujarour, 2010, Genome-wide gain-of-function screen identifies novel regulators of pluripotency, Stem Cells, 28, 1487, 10.1002/stem.472 Savkur, 1998, Preferential cleavage in pre-ribosomal RNA byprotein B23 endoribonuclease, Nucleic Acids Res, 26, 4508, 10.1093/nar/26.19.4508 Lin, 2016, The nucleolar protein NIFK promotes cancer progression via CK1α/β-catenin in metastasis and Ki-67-dependent cell proliferation, Elife, 5, e11288, 10.7554/eLife.11288 Blum, 2018, Zenklusen JC. SnapShot: TCGA-Analyzed Tumors, Cell, 173, 530, 10.1016/j.cell.2018.03.059 Yu, 2012, clusterProfiler: an R package for comparing biological themes among gene clusters, Omics, 16, 284, 10.1089/omi.2011.0118 Chandrashekar, 2017, UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses, Neoplasia, 19, 649, 10.1016/j.neo.2017.05.002 Chandrashekar, 2022, UALCAN: An update to the integrated cancer data analysis platform, Neoplasia, 25, 18, 10.1016/j.neo.2022.01.001 Li, 2017, TIMER: A web server for comprehensive analysis of tumor-infiltrating immune cells, Cancer Res, 77, e108, 10.1158/0008-5472.CAN-17-0307 Cheng, 2018, Capn4 promotes colorectal cancer cell proliferation by increasing MAPK7 through activation of the WNT/β-Catenin pathway, Exp Cell Res, 363, 235, 10.1016/j.yexcr.2018.01.013 Zeng, 2021, Employing hypoxia characterization to predict tumour immune microenvironment, treatment sensitivity and prognosis in hepatocellular carcinoma, Comput Struct Biotechnol J, 19, 2775, 10.1016/j.csbj.2021.03.033 Mossanen, 2013, Role of lymphocytes in liver cancer, Oncoimmunology, 2, e26468, 10.4161/onci.26468 Anwanwan, 2020, Challenges in liver cancer and possible treatment approaches, Biochim Biophys Acta Rev Cancer, 1873, 188314, 10.1016/j.bbcan.2019.188314 Tabrizian, 2015, Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis, Ann Surg, 261, 947, 10.1097/SLA.0000000000000710 Craig, 2016, Liver capsule: Molecular-based signatures in hepatocellular carcinoma, Hepatology, 63, 2018, 10.1002/hep.28489 Lyman, 1999, Human Nop5/Nop58 is a component common to the box C/D small nucleolar ribonucleoproteins, RNA, 5, 1597, 10.1017/S1355838299991288 Wang, 2021, Overexpression of NOP58 as a prognostic marker in hepatocellular carcinoma: A TCGA data-based analysis, Adv Ther, 38, 3342, 10.1007/s12325-021-01762-2 He, 2020, WNT/β-catenin signaling in the development of liver cancers, Biomed Pharmacother, 132, 110851, 10.1016/j.biopha.2020.110851 Delire, 2015, The Ras/MAPK pathway and hepatocarcinoma: pathogenesis and therapeutic implications, Eur J Clin Invest, 45, 609, 10.1111/eci.12441 Chen, 2019, Immunomodulatory TGF-β signaling in hepatocellular carcinoma, Trends Mol Med, 25, 1010, 10.1016/j.molmed.2019.06.007 Zhu, 2021, Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features, J Hepatol, 74, 613, 10.1016/j.jhep.2020.09.032 Oura, 2021, Tumor immune microenvironment and immunosuppressive therapy in hepatocellular carcinoma: a review, Int J Mol Sci, 22, 10.3390/ijms22115801 Heinrich, 2022, The tumour microenvironment shapes innate lymphoid cells in patients with hepatocellular carcinoma, Gut, 71, 1161, 10.1136/gutjnl-2021-325288